Meeting with the European Commission’s DG SANTE
PAREA met with Director for Health Systems, Medical Products and Innovation - Andrzej Ryś. The Commission is currently performing an extensive revision of the EU General Pharmaceutical Legislation and PAREA was requested to provide additional information on the psychedelic therapies, which could feed into the revision process. Additionally, following PAREA’s suggestion to organize an EU institution-led workshop exploring the future of psychedelics in Europe, the EC advised that PAREA engages with EMA in this regard. EMA would be best placed to organize such an event with the US NIH/FDA and in collaboration with other EU institutions.